About the Authors
- Thuy T. Le
-
Affiliation Inflammation Biology, and Cancer Drug Mechanism Laboratories, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
- Kresten Skak
-
Affiliation Leo Pharma, Copenhagen, Denmark
- Kate Schroder
-
Affiliation Inflammasome Laboratory, Institute for Molecular Bioscience and Australian Infectious Diseases Research Centre, University of Queensland, Brisbane, Queensland, Australia
- Wayne A. Schroder
-
Affiliation Inflammation Biology, and Cancer Drug Mechanism Laboratories, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
- Glen M. Boyle
-
Affiliation Inflammation Biology, and Cancer Drug Mechanism Laboratories, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
- Carly J. Pierce
-
Affiliation Inflammation Biology, and Cancer Drug Mechanism Laboratories, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
- Andreas Suhrbier
-
* E-mail: Andreas.Suhrbier@qimrberghofer.edu.au
Affiliation Inflammation Biology, and Cancer Drug Mechanism Laboratories, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
Competing Interests
K. Skak is an employee of Leo Pharma. AS was a paid consultant for Leo Pharma in 2011. AS is an inventor on a series of patents covering ingenol mebutate (Picato), but receives no royalties or financial (or other) benefits as a result. These commercial affiliations do not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: K. Schroder K. Skak AS WS GB. Performed the experiments: TTL K. Schroder WS CP. Analyzed the data: K. Schroder AS. Contributed reagents/materials/analysis tools: K. Skak GB CP. Wrote the paper: AS.